Maryland House Bill 756 (Prior Session Legislation)

---

Sponsorship: Partisan Bill (Republican 1)
Status: Introduced on January 31 2020 - 25% progression, died in committee
Action: 2020-02-06 - Hearing 2/27 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for drug products for which there is a certain generic equivalent; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus the fee-for-service professional dispensing fee determined by the Maryland Department of Health in accordance with the most recent in-State cost-of-dispensing survey; etc.

Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers - Reimbursement Requirements

Del. Nicholaus Kipke [R]

Date	Chamber	Action
2020-02-06	House	Hearing 2/27 at 1:00 p.m.
2020-01-31	House	First Reading Health and Government Operations

HB756 (Carry Over) 2020-02-06 - Hearing 2/27 at 1:00 p.m.

Chapter	Article	Section	Citation Type	Statute Text
Health - General	15	118	(n/a)	See Bill Text
Insurance	15	1632	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0756?ys=2020RS
Text	https://mgaleg.maryland.gov/2020RS/bills/hb/hb0756f.pdf